ABSTRACT

It is well recognized that there is wide interindividual variability in drug response. Given

the same dosage of a drug, some patients experience complete remission, some fail to

respond, and others experience severe toxicities. These differences in drug response are

influenced by many factors, including demographics (age, sex, ethnicity), organ function

and comorbidities, environmental exposures (diet, carcinogen exposure, drug inter-

actions), and genetics (Fig. 1). In general, genetic factors are estimated to account for 15%

to 30% of interindividual variability in drug response, but for certain drugs, genetic

factors could explain up to 95% of this variation (1-4). The term “pharmacogenetics” was

coined almost 50 years ago to refer to the role of inherited genetic variation in prediction

of drug response (5). Earlier pharmacogenetic studies focused on pharmacokinetics, or the

way the body metabolizes a drug and controls the amount of the drug at the site of action,

which includes the absorption, distribution, metabolism, and excretion (ADME) of the

drug. Almost all of the classic examples of pharmacogenetics (e.g., NAT2, CYP2D6,

CYP2C19, TPMT, UGT1A1) have come from studies of pharmacokinetics. This area of

pharmacogenetics, related to pharmacokinetics, continues to attract much attention, with

growing research in drug transporter and metabolizing enzymes. The second component

of pharmacogenetics is pharmacodynamics, which involves the mechanisms of drug action.

With the completion of the human genome, the international Hapmap project, and rapid

advance of high-throughput whole-genome technologies, the field of pharmacogenetics has

been undergoing a steady evolution from the study of monogenic traits to that of polygenic

traits, and from small-scale candidate approach to comprehensive and whole-genome

approaches. The newer term “pharmacogenomics” reflects such an evolution, which often

involves large-scale, genomewide analysis to identify genetic factors relevant to drug

response. However, these two terms are often used interchangeably.